# Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes

> **NCT00048100** · PHASE1 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 2 (actual)

## Conditions studied

- Leukemia, Myelocytic, Acute

## Interventions

- **PROCEDURE:** Apheresis
- **BIOLOGICAL:** Stem Cell Transplant

## Key facts

- **NCT ID:** NCT00048100
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-02
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Slow accrual.
- **Last updated:** 2018-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00048100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00048100, "Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00048100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*